Literature DB >> 17597489

Humoral immune responses against norovirus infections of children.

Nobuhiro Iritani1, Toshiyuki Seto, Hideji Hattori, Katsurou Natori, Naokazu Takeda, Hideyuki Kubo, Tsunekazu Yamano, Minoru Ayata, Hisashi Ogura, Yoshiyuki Seto.   

Abstract

In 2 infants with gastroenteritis associated with Norovirus (NoV), serum immunoglobulin (Ig) G, IgM, IgA, and fecal IgA antibody responses against NoV were examined by enzyme-linked immunosorbent assay using 11 different antigenic and genetic types of NoV virus-like particles expressed in insect cells. These two cases were putative primary single NoV infections, because antibodies against NoVs were not detected in acute-phase serums. In one of two cases, long-term excretion of virus RNA for 33 days was observed. Serum IgG responses demonstrated strong seroresponse to the homologous type, and weak seroresponse to the heterologous types within the genogroup. After more than 2 years, the IgG antibody titer remained high to the homologous type and low to the heterologous type within the genogroup. IgM and IgA were specific to the homologous type. IgM was short lived and the serum IgA antibody titer remained low to the homologous type for a long period. These results improve our understanding of the humoral immune response to NoV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597489     DOI: 10.1002/jmv.20897

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.

Authors:  Jacob Kocher; Tammy Bui; Ernawati Giri-Rachman; Ke Wen; Guohua Li; Xingdong Yang; Fangning Liu; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity.

Authors:  Rita Czakó; Robert L Atmar; Antone R Opekun; Mark A Gilger; David Y Graham; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

Review 4.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

5.  Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease.

Authors:  Pengbo Liu; Xiaoqin Wang; Joong-Chul Lee; Peter Teunis; Senke Hu; Helen Tang Paradise; Christine Moe
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

6.  Birth Cohort Studies: Toward Understanding Protective Immunity to Human Noroviruses.

Authors:  Robert L Atmar; Sasirekha Ramani
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

7.  Production and Characterization of Mouse Monoclonal Antibodies Recognizing Human Pan-IgG Specific Conformational or Linear Epitopes.

Authors:  Fatemeh Hajighasemi; Jalal Khoshnoodi; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2012-10

Review 8.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

9.  Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography.

Authors:  L Huhti; K Tamminen; T Vesikari; V Blazevic
Journal:  Arch Virol       Date:  2012-12-11       Impact factor: 2.574

10.  Probiotic stool secretory immunoglobulin A modulation in children with gastroenteritis: a randomized clinical trial.

Authors:  Stephen B Freedman; Rachael Horne; Kathene Johnson-Henry; Jianling Xie; Sarah Williamson-Urquhart; Linda Chui; Xiao-Li Pang; Bonita Lee; Suzanne Schuh; Yaron Finkelstein; Serge Gouin; Ken J Farion; Naveen Poonai; Katrina Hurley; David Schnadower; Philip M Sherman
Journal:  Am J Clin Nutr       Date:  2021-04-06       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.